Neuroprotective and Neurorestorative Effects of
Holothuria scabra
MPP+
MPTP
striatal dopamine
tyrosine hydroxylase
α-synuclein
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
06
2020
accepted:
18
11
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
8
1
2021
Statut:
epublish
Résumé
Extracts from
Identifiants
pubmed: 33408606
doi: 10.3389/fnins.2020.575459
pmc: PMC7779621
doi:
Types de publication
Journal Article
Langues
eng
Pagination
575459Informations de copyright
Copyright © 2020 Noonong, Sobhon, Sroyraya and Chaithirayanon.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Neurosci. 2002 Nov;5 Suppl:1058-61
pubmed: 12403986
Mol Neurodegener. 2017 Jan 24;12(1):10
pubmed: 28118852
Science. 2003 Oct 31;302(5646):819-22
pubmed: 14593166
Neuroreport. 2000 Apr 7;11(5):1093-6
pubmed: 10790888
Curr Neuropharmacol. 2018;16(7):1086-1097
pubmed: 29189163
Phytother Res. 2015 Feb;29(2):187-200
pubmed: 25408503
Bio Protoc. 2019 Jan 5;9(1):
pubmed: 30687773
J Tradit Complement Med. 2017 Jul 17;8(3):341-351
pubmed: 29992105
Parkinsonism Relat Disord. 2008;14 Suppl 2:S189-93
pubmed: 18579428
Molecules. 2017 Jun 09;22(6):
pubmed: 28598384
Int J Mol Sci. 2018 May 02;19(5):
pubmed: 29724051
Neural Plast. 2017;2017:5012129
pubmed: 28133550
Comp Biochem Physiol B Biochem Mol Biol. 2015 Feb;180:16-39
pubmed: 25263252
Curr Drug Metab. 2017;18(1):50-61
pubmed: 27396919
Redox Biol. 2018 Jun;16:47-58
pubmed: 29475134
Int J Mol Sci. 2015 Sep 01;16(9):20704-30
pubmed: 26340618
Neuroreport. 2009 Apr 22;20(6):569-73
pubmed: 19287320
J Neurochem. 2009 Nov;111(4):1042-50
pubmed: 19765187
Int J Mol Sci. 2014 Jan 22;15(1):1625-46
pubmed: 24451142
Restor Neurol Neurosci. 2000;16(2):135-142
pubmed: 12671216
Mol Cell Biochem. 2012 May;364(1-2):209-16
pubmed: 22278385
Mar Drugs. 2011;9(10):1761-805
pubmed: 22072996
Neurosci Lett. 1985 Sep 30;60(2):109-14
pubmed: 3877260
Front Pharmacol. 2019 Mar 19;9:1555
pubmed: 30941047
J Parkinsons Dis. 2011;1(1):19-33
pubmed: 23275799
Exp Mol Med. 2007 Jun 30;39(3):376-84
pubmed: 17603292
Rejuvenation Res. 2010 Feb;13(1):55-64
pubmed: 20230279
J Chem Neuroanat. 2018 Sep;91:46-54
pubmed: 29694842
Chin Med J (Engl). 2010 Apr 20;123(8):1086-92
pubmed: 20497720
Mol Med Rep. 2016 Sep;14(3):2397-404
pubmed: 27484986
Exp Neurol. 2017 Dec;298(Pt B):137-147
pubmed: 28988910
Nutr Neurosci. 2018 Jul;21(6):427-438
pubmed: 28276260
Biochim Biophys Acta. 2014 Aug;1842(8):1282-94
pubmed: 24060637
Front Neurol. 2018 May 04;9:295
pubmed: 29780350
Mov Disord. 2010;25 Suppl 1:S155-60
pubmed: 20187246
Evid Based Complement Alternat Med. 2015;2015:626028
pubmed: 26664453
Parkinsons Dis. 2011 Mar 15;2011:716871
pubmed: 21461368
J Neurosci Res. 1991 Dec;30(4):666-72
pubmed: 1686284
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S143-6
pubmed: 22166416
Neural Regen Res. 2014 Aug 15;9(16):1557-66
pubmed: 25317174